Imerja wins transPennine deal
Imerja, a Bolton-based IT services provider, has won a transPennine deal worth £750,000 over three years.
Biotechnology giant Amgen is selling the Japanese rights to up to 13 of its experimental drugs to Takeda Pharmaceutical of Japan in a deal that might bring Amgen more than $1 billion.